S&P 500
(0.25%) 5 112.90 points
Dow Jones
(0.21%) 38 319 points
Nasdaq
(0.28%) 15 973 points
Oil
(-1.01%) $83.00
Gas
(4.84%) $2.02
Gold
(0.07%) $2 348.90
Silver
(0.27%) $27.61
Platinum
(4.05%) $959.45
USD/EUR
(-0.18%) $0.933
USD/NOK
(-0.30%) $10.99
USD/GBP
(-0.48%) $0.797
USD/RUB
(1.73%) $93.46

实时更新: Spyre Therapeutics, Inc. [SYRE]

交易所: NASDAQ Capital Market 部门: Healthcare 工业: Biotechnology
BUY
50.00%
return -3.79%
SELL
0.00%
return 9.94%
最后更新时间30 Apr 2024 @ 00:02

5.13% $ 35.28

购买 107707 min ago

@ $22.52

发出时间: 15 Feb 2024 @ 04:56


回报率: 56.66%


上一信号: Feb 14 - 22:38


上一信号: 出售


回报率: -2.04 %

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 00:02):

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection...

Stats
今日成交量 53 582.00
平均成交量 501 401
市值 1.28B
EPS $-3.43 ( 2023-11-09 )
下一个收益日期 ( $-0.900 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0.190 (0.54%)
Insider Trading
Date Person Action Amount type
2024-04-25 Fairmount Funds Management Llc Buy 3 639 680 Common Stock
2024-04-25 Fairmount Funds Management Llc Sell 90 992 Series A Preferred Stock
2024-02-15 Turtle Cameron Buy 400 Common Stock
2024-02-01 Mckenna Mark C. Buy 40 000 Stock Option (Right to Buy)
2024-02-01 Mckenna Mark C. Sell 477 000 Stock Option (Right to Buy)
INSIDER POWER
12.68
Last 11 transactions
Buy: 4 513 535 | Sell: 4 003 472

音量 相关性

長: -0.16 (neutral)
短: -0.58 (weak negative)
Signal:(52.986) Neutral

Spyre Therapeutics, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Spyre Therapeutics, Inc. 相关性 - 货币/商品

The country flag 0.80
( moderate )
The country flag 0.85
( strong )
The country flag 0.52
( weak )
The country flag 0.83
( strong )
The country flag -0.49
( neutral )
The country flag -0.82
( strong negative )

Spyre Therapeutics, Inc. 财务报表

Annual 2023
营收: $886 000
毛利润: $-78 000.00 (-8.80 %)
EPS: $-49.12
FY 2023
营收: $886 000
毛利润: $-78 000.00 (-8.80 %)
EPS: $-49.12

Financial Reports:

No articles found.

Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. The company's pipeline includes extended half-life antibodies targeting a4ß7, TL1A, and IL-23. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。